Bevacizumab plus chemotherapy in nonsquamous non‐small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B

Background Pleurodesis is the standard of care for non‐small cell lung cancer (NSCLC) patients with symptomatic malignant pleural effusion (MPE). However, there is no standard management for MPE uncontrolled by pleurodesis. Most patients with unsuccessful MPE control are unable to receive effective...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rintaro Noro, Kunihiko Kobayashi, Jiro Usuki, Makiko Yomota, Masaru Nishitsuji, Tsuneo Shimokawa, Masahiro Ando, Mitsunori Hino, Koichi Hagiwara, Akihiko Miyanaga, Masahiro Seike, Kaoru Kubota, Akihiko Gemma, North East Japan Study group
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2020-07-01
Colecção:Thoracic Cancer
Assuntos:
Bevacizumab plus chemotherapy
non‐small cell lung cancer
unsuccessful management of malignant pleural effusion
vascular endothelial growth factor
Acesso em linha:https://doi.org/10.1111/1759-7714.13472
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados